Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
23:14:48 EDT Sun 11 Oct 2026
Enter Symbol
or Name
USA
CA



News last 24 hour(s) - 15 items News ReleasesIn The NewsOther CAUS
DateSymPriceTypeHeadline
2026-10-11 23:14U:SKYANews ReleaseSkyAI Announces Intention to Commence Cash Tender Offer to Purchase Common Stock and Pre-funded Warrants at $3.00 Per Share/Pre-funded Warrant
2026-10-11 21:00U:PLTRNews ReleasePalantir Technologies Announces October Seoul Pop-Up with Korea-First Exclusive Merchandise Release
2026-10-11 20:35U:PALAFNews ReleaseSeptember 2026 Quarterly Results Conference Call
2026-10-11 20:30U:SCAGNews ReleaseScage Future Provides Business Update on Deliveries, Technology Portfolio and Growth Initiatives; Initiates Regular Investor Communication
2026-10-11 20:22U:FFRNews ReleaseFF EAI Robotics Ecosystem Inc. (NASDAQ: FFR) Highlights Faraday Future Announcement: This Week's Investor Weekly Report from YT Jia Rescheduled to October 14; FFR and FFAI to Host Joint New Product Launch Event on October 14
2026-10-11 20:22U:FFAINews ReleaseFF EAI Robotics Ecosystem Inc. (NASDAQ: FFR) Highlights Faraday Future Announcement: This Week's Investor Weekly Report from YT Jia Rescheduled to October 14; FFR and FFAI to Host Joint New Product Launch Event on October 14
2026-10-11 19:00U:FFAINews ReleaseFaraday Future Announces This Week's Investor Weekly Report from YT Jia Has Been Rescheduled to October 14; FFR and FFAI to Host Joint New Product Launch Event on October 14
2026-10-11 17:00U:MIRMNews ReleaseMirum Pharmaceuticals to Host Investor Call to Share Topline Results from the Phase 3 EXPAND Study of LIVMARLI(TM) (maralixibat) in Ultra-Rare Cholestatic Liver Diseases
2026-10-11 16:00U:TRAXNews ReleaseFirst Tracks Biotherapeutics to Announce Top-Line Data from Cohort 1 of Phase 1b Trial of ANB033, a CD122 antagonist, in Celiac Disease on Oct. 12, 2026
2026-10-11 14:30U:BBIONews ReleaseAcoramidis Associated with Significantly Improved Clinical Outcomes Versus Tafamidis in ATTR-CM in an Independent, Real-World Study of U.S. Electronic Health Records
2026-10-11 13:40U:STLANews ReleaseStellantis Unveils Six Concept Cars "The Night Before" the Paris Motor Show
2026-10-11 13:00U:FRNMNews ReleaseFreenome to Present New Validation Data for Next-Generation CRC Screening Test in Late-Breaking Oral Presentation at ACG 2026
2026-10-11 13:00U:ABBVNews ReleaseNew SKYRIZI(TM) (risankizumab-rzaa) and RINVOQ(TM) (upadacitinib) Data Demonstrate Disease Control for Patients Living With Inflammatory Bowel Disease
2026-10-11 11:42U:BBIONews ReleaseEncaleret Increased Bone Turnover and Improved Participant-Reported Symptoms in the Phase 3 CALIBRATE Trial in ADH1
2026-10-11 10:44U:LVSNews Release'NBA Cares x Sands Cares Community Impact Week 2026' Successfully Concludes